Véronique Leblond

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq et al. · The Lancet Infectious Diseases · 2017 · 556 citations · Full text

Prognostic Factors, Foodborne Illness, Clinical Features +6

High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: Up-front or Rescue Treatment? Results of a Multicenter Sequential Randomized Clinical Trial

Jean‐Paul Fermand, Philippe Ravaud, Sylvie Chevret et al. · Blood · 1998 · 539 citations

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

Arnaud Jaccard, Philippe Moreau, Véronique Leblond et al. · New England Journal of Medicine · 2007 · 514 citations

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Constantine S. Tam, Stephen Opat, Shirley D’Sa et al. · Blood · 2020 · 432 citations · Full text

International prognostic scoring system for Waldenström macroglobulinemia

Pierre Morel, Alain Duhamel, Paolo G. Gobbi et al. · Blood · 2009 · 404 citations · Full text